CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma

被引：4
|
作者：
Hadidi, Samer Al [1 ,3 ]
Cliff, Edward R. S. [2 ]
机构：
[1] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Little Rock, AR USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law, Boston, MA USA
[3] Univ Arkansas Med Sci, Myeloma Ctr, Winthrop P Rock efeller Canc Inst, Little Rock, AR 72205 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2023年 / 182卷
关键词：
D O I：
10.1016/j.ejca.2022.12.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Re: CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma
    Mi, Jian-Qing
    Zhao, Wanhong
    Jing, Hongmei
    Jin, Jie
    Chen, Sai-Juan
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 108 - 110
  • [2] Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)
    Mi, Jian-Qing
    Zhao, Wanhong
    Jing, Hongmei
    Fu, Weijun
    Hu, Jianda
    Chen, Lijuan
    Zhang, Yiwen
    Yao, Dan
    Chen, Diana
    Schecter, Jordan M.
    Yang, Fan
    Tian, Xiaochen
    Sun, Huabin
    Zhuang, Sen Hong
    Ren, Jimmy
    Fan, Xiaohu
    Jin, Jie
    Niu, Ting
    Chen, Sai-Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1275 - +
  • [3] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
  • [4] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [5] Chimeric antigen receptor-T-cell therapy: China leading the way
    Gale, Robert Peter
    BLOOD SCIENCE, 2022, 4 (03): : 176 - 176
  • [6] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Wang, Zehua
    Chen, Chen
    Wang, Lei
    Jia, Yongxu
    Qin, Yanru
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
    Hosen, Naoki
    CANCERS, 2019, 11 (12)
  • [8] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Hosen, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
  • [9] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
    Atrash, Shebli
    Ali, Syed Abbas
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 21 - 34
  • [10] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Naoki Hosen
    International Journal of Hematology, 2020, 111 : 530 - 534
12345